Name: Disease Burden of Spinal Disorders in Brazil (en Inglés)
Price: 225.60 PEN
Availability: InStock
Author: Deligne, Lucas de Melo Castro ; Darmstadter, Henrique Elias ; Dias, Paulo Feliciano Sarquis
ISBN: 9786205642696

portada Disease Burden of Spinal Disorders in Brazil (en Inglés)

Formato

Libro Físico

Autor

Henrique Elias Darmstadter

Lucas de Melo Castro Deligne

Editorial

Our Knowledge Publishing

Idioma

Inglés

N° páginas

Encuadernación

Tapa Blanda

Dimensiones

22.9 x 15.2 x 0.5 cm

Peso

0.13 kg.

ISBN13

9786205642696

Categorías

Cuestiones generales de la medicina

Disease Burden of Spinal Disorders in Brazil (en Inglés)

Henrique Elias Darmstadter (Autor) · Lucas de Melo Castro Deligne (Autor) · Our Knowledge Publishing · Tapa Blanda

Libro Nuevo

S/ 225,60

S/ 376,00

Ahorras: S/ 150,40

40% descuento

Envío normal

Origen: Estados Unidos (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Miércoles 17 de Julio y el Viernes 26 de Julio.

Lo recibirás en cualquier lugar de Perú entre 2 y 5 días hábiles luego del envío.

Reseña del libro "Disease Burden of Spinal Disorders in Brazil (en Inglés)"

Musculoskeletal diseases (MSD) are defined as changes in muscles, joints, tendons, ligaments, nerves, cartilage, and bones. The most associated independent risk factors are: age over 30 years, female gender, smoking, alcoholism, obesity, poor posture, pain intensity, mood disorders, low social and educational level, sedentary lifestyle and work activities that require efforts with excessive flexion, rotation, trunk vibration and excess load. The association of these individual, organizational, sociocultural and psychosocial factors contribute to the onset and chronicity of MSDs.The progressive increase in life expectancy of the population leads to a change in the global epidemiological profile. The increase in the prevalence of chronic degenerative diseases over the years requires restructuring in public health policy practices, in order to seek new solutions to reduce the impact of MSDs on the population, as well as to deal with the costs of diagnostic procedures and treatments inherent to these conditions.